News/Event
Latest Headlines featuring iProgen Biotech
iProgen Biotech:
News Spotlight
Stay up-to-date with the latest breakthroughs, press releases, and exciting developments at iProgen Biotech. Follow our journey as we continue to make strides in the biotech industry.
-
iProgen Out-Licenses AntibodyInternalization Technologies to AOCeraTherapeutics for Antibody Oligo ConjugateApplication.
May 29, 2026iProgen Biotech out-licensed its Antibody Internalization Technologies to AOCeraTherapeutics Inc. (www.AOCera.com), headquartered in San Diego, USA. AOCeraTherapeutics is a biotechnology company developing precision medicines that useantibody-oligonucleotide conjugate (AOC) technology to deliver RNA therapeuticsdirectly to...
-
29 May 2026 iProgen Out-Licenses AntibodyInternalization Technologies to AOCeraTherapeutics for Antibody Oligo ConjugateApplication.May 29, 2026iProgen Biotech out-licensed its Antibody Internalization Technologies to AOCeraTherapeutics Inc. (www.AOCera.com), headquartered in San Diego, USA....
-
25 June 2025 iProgen and UBC Out-License NovelDegrader Antibody ConjugateTechnology to 3C Therapeutics Inc.iProgen Biotech and the University of British Columbia (UBC) have jointly out-licensed their novel modular Degrader Antibody Conjugate...
-
03 September 2024 iProgen has out-licensed its protein internalization technology to Lucy Biotech Ltd. for the delivery of Anti-Freeze ProteinsiProgen Biotech out-licensed its intracellular protein delivery technology for enhanced delivery of antifreeze proteins to Lucy Biotech Ltd.,...
-
01 July 2023 iProgen and Korean Basic Science Institute (KBSI) launches ADC research collaboration to treat Osteoporosis using Antibody Drug Conjugate technologyKorean Basic Science Institute (KBSI) and iProgen Biotech Inc. enters research collaboration to explore the application of Antibody...
-
13 April 2022 Pioneering research collaboration to treat Sarcopenia using Antibody Drug Conjugate technologyAsan Medical Center (AMC) and iProgen Biotech Inc., enters research collaboration to explore the application of Antibody Drug...
-
01 April 2022 iProgen and UBC launches ADC research collaboration to develop novel antibody-PROTAC technologyNational Science and Engineering Research Council approves grant to support two-year novel antibody-PROTAC technology research and development. UBC...
-
01 November 2021 iProgen and Biorchestra launches research collaboration to explore applications of Antibody Oligo Conjugates to treat diseases with unmet medical needsBiorchestra and iProgen have been approved for an International Research Grant application (Canada-Korea) to work on the research...
-
28 October 2020 East-West academic-industry research collaboration to identify lung cancer biomarkersRIKEN Research Institute, KEIO Medical University, iPrime Therapeutics Co. Ltd., and iProgen Biotech enters joint research collaboration to...
-
07 April 2019 Celltrion Partners with iProgen Biotech to develop a series of novel ADCsCelltrion signs a partnership deal with the Canada-based iProgen Biotech Inc. to bolster its pipeline for novel biotherapeutics....
iProgen On The Move:
Upcoming Conferences and Events
Discover where iProgen will be next. Join us at upcoming conferences, trade shows, and industry events as we share our cutting-edge innovations and network with peers.
iProgen Biotech:
iProgen's Legacy: Our Journey Through Biotech
Explore iProgen’s rich history of participation and achievements. From past conferences to trade shows, our commitment to biotech advancement is always on display.
Begin Your Journey with Us Today
Catch Up on Our Exciting News and Opportunities!
No form exists.